garenoxacin has been researched along with sulbactam in 1 studies
| Studies (garenoxacin) | Trials (garenoxacin) | Recent Studies (post-2010) (garenoxacin) | Studies (sulbactam) | Trials (sulbactam) | Recent Studies (post-2010) (sulbactam) |
|---|---|---|---|---|---|
| 195 | 19 | 46 | 1,844 | 297 | 488 |
| Protein | Taxonomy | garenoxacin (IC50) | sulbactam (IC50) |
|---|---|---|---|
| Beta-lactamase | Escherichia coli | 6.2 | |
| Beta-lactamase | Shouchella clausii | 0.075 | |
| Beta-lactamase | Pseudomonas aeruginosa | 0.37 | |
| Beta-lactamase | Pseudomonas aeruginosa | 3 | |
| Beta-lactamase | Aeromonas allosaccharophila | 4 | |
| Beta-lactamase | Staphylococcus aureus | 6.5 | |
| Beta-lactamase | Enterobacter cloacae | 1.4 | |
| Beta-lactamase TEM | Escherichia coli | 4.3 | |
| Beta-lactamase | Acinetobacter pittii | 1.12 | |
| Beta-lactamase | Acinetobacter pittii | 7.758 | |
| Beta-lactamase | Pseudomonas aeruginosa | 3 | |
| Beta-lactamase | Escherichia coli | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, J; Higa, F; Hiramatsu, K; Kadota, J; Kohno, S; Tateyama, M; Tokimatsu, I; Yamamoto, Y; Yanagihara, K | 1 |
1 trial(s) available for garenoxacin and sulbactam
| Article | Year |
|---|---|
Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan.
Topics: Administration, Oral; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Injections, Intravenous; Japan; Male; Middle Aged; Pneumonia, Bacterial; Recurrence; Sulbactam; Treatment Outcome | 2013 |